Barbara Ryan
Barbara Ryan
Barbara Ryan Colemanis a fictional character from the American CBS soap opera As the World Turns. In the early 1970s, Barbara was played by a succession of actresses, but the actress most associated with the role is Colleen Zenk, who played her since September 1, 1978. Better known as simply Barbara Ryan she is portrayed as a heroine who experienced many tragedies, mostly at the hands of her controlling ex-husband, the villainous James Stenbeck...
anyone becoming environment helped labels people
That hasn't helped anyone much. We're in an environment now where labels are becoming so riddled with warnings that people don't know what to do.
against charged diseases issue people sexually talking
It's a potentially politically charged issue because you're talking about vaccinating people against sexually transmitted diseases when they're 12 or 13.
blindness certainly diabetes evidence form linking people risk risks viagra
I just don't think it's a big deal, ... There certainly isn't any evidence linking Viagra with these reports. There is a risk with this form of blindness from diabetes and cardiovascular disease, and those are also risks for erectile dysfunction or impotence, which is also why people take Viagra.
obviously people vaccine
If it's universally recommended then obviously people are going to be getting the vaccine much more broadly.
beyond goes market maybe people reasons relationship sex
I think the market is pretty well defined. There are many reasons people don't have sex. Maybe they have relationship dysfunction. Sex goes beyond just getting an erection.
change higher people point
It doesn't change much. But it does point people to the higher end of the range.
avoid condition educate people
You want to educate people on the condition and how to avoid it.
companies strong survive
Strong companies are going to survive in this sector, and they're going to look more like Pfizer than not.
heroic stretch
The restructuring is not heroic by any stretch of the imagination.
business good price
They can get a good price for it and it's probably undervalued in their portfolio. It's not so much about them getting out of that business much as it's about unleashing shareholder value.
based cost earnings expect recovery year
Bristol-Myers earnings will be down this year but then we expect to see a recovery based on the introduction of new drugs and cost cuts.
aided company deliver despite earnings faced pressures top
Despite the pressures that Pfizer has faced and will face on the top line, the company will be able to deliver on their earnings target, in part aided by introduction of their new drugs.
clear detail heard humbled loud management recognize team
You're going to see a much more transparent and humbled management team with a lot more detail and granularity on a whole lot of issues, which is not characteristic of Pfizer historically. They have heard their shareholders loud and clear and recognize that they need to be transparent and more visible.
beyond both gets good patents victory won
This is as good as it gets for Pfizer. They won a victory on both patents -- well beyond our expectations.